Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

RNA-based therapies have catalyzed a revolutionary transformation in the biomedical
landscape, offering unprecedented potential in disease prevention and treatment. However …

Drug-resistant bacterial infection and low healing efficiency in motion skin wounds impose
significant new requirements on design of wound dressings in terms of flexibility, self …

The unique network characteristics and stimuli responsiveness of supramolecular hydrogels
have rendered them highly advantageous in the field of wound dressings, showcasing …

Owing to the variety and complexity of ocular diseases and the natural ocular barriers, drug
therapy for ocular diseases has significant limitations, such as poor drug targeting to the site …

Ocular diseases profoundly impact patients' vision and overall quality of life globally.
However, effective ocular drug delivery presents formidable challenges within clinical …

Neovascular age-related macular degeneration (AMD), a leading cause of blindness,
requires frequent intravitreal injection of antivascular endothelial growth factor (anti-VEGF) …

We report the successful synthesis of an injectable dendrimer hydrogel (DH) carrying
melphalan, a clinical drug for retinoblastoma treatment, in both conjugated and free forms …

The human eye's intricate anatomical and physiological design necessitates tailored
approaches for managing ocular diseases. Recent advancements in ophthalmology …

Reactive oxygen species (ROS) have been recognized as prevalent contributors to the
development of inner retinal injuries including optic neuropathies such as glaucoma, non …